MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcard.2023.131236

Медицинская библиотека · International journal of cardiology · 2023

Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.

Barki Monica, Ielasi Alfonso, Buono Andrea, Maffeo Diego, Montonati Carolina, Pellegrini Dario, Pellicano Mariano, Gorla Riccardo, Costa Giuliano, Cozzi Ottavia, Ancona Marco, Soriano Francesco, De Carlo Marco, Ferrara Erica, Giannini Francesco, Massussi Mauro, Fovino Luca Nai, Messina Antonio, Sgroi Carmelo, Gallo Francesco, Nerla Roberto, Saccocci Matteo, D'Ascenzo Fabrizio, Conrotto Federico, Bettari Luca, Fiorina Claudia, Castriota Fausto, Poli Arnaldo, Petronio Anna Sonia, Oreglia Jacopo, Montorfano Matteo, Regazzoli Damiano, Reimers Bernhard, Barbanti Marco, Tamburino Corrado, Bedogni Francesco, Tarantini Giuseppe, Tespili Maurizio

Многоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Horizontal aorta (HA), defined by an aortic angulation (AA) ≥48°, is associated with worse outcomes particularly after self-expanding (SE) trans-catheter heart valve (THV) implantation. Although the SE ACURATE Neo THV demonstrated favorable procedural success rates in patients with HA, it remains associated with a non-negligible rate of moderate or greater paravalvular leak (PVL).

OBJECTIVES

Aim of the study was to assess the performance of ACURATE Neo2 in the setting of HA.

METHODS

We performed a multicenter cohort analysis on patients with severe aortic valve stenosis and HA undergoing transcatheter aortic valve replacement (TAVR) with the Neo or Neo2 THV enrolled in the ITAL-neo registry. The primary endpoint was a composite of early safety and clinical efficacy at 30 days according to the Valve Academic Research Consortium-3 (VARC-3). Secondary endpoints included the occurrence of moderate or severe PVL and 90-day clinical outcomes.

RESULTS

Among 900 patients included in the ITAL-neo registry, 407 exhibited HA; of these, 300 received a Neo THV and 107 a Neo2 THV. HA, irrespective of the THV implanted, emerged as an independent risk factor for developing ≥ moderate PVL. Technical and device success at 30-day follow-up was comparable between groups. However, Neo2 was associated with a significantly lower rate of ≥moderate PVL vs. Neo: (5% vs. 15%; p < 0.001), which was confirmed also at 90-day follow-up. Additionally, no correlation was found between ≥moderate PVL and AA in the Neo2 group, while PVL degree increased proportionally to the AA in the Neo cohort.

CONCLUSION

In patients with HA, the new generation Acurate Neo2 THV was associated with a comparable device success rate and a significantly lower rate of ≥moderate PVL, when compared with its predecessor.

Для цитирования: Barki Monica, Ielasi Alfonso, Buono Andrea, Maffeo Diego, Montonati Carolina, Pellegrini Dario, Pellicano Mariano, Gorla Riccardo, Costa Giuliano, Cozzi Ottavia, Ancona Marco, Soriano Francesco, De Carlo Marco, Ferrara Erica, Giannini Francesco, Massussi Mauro, Fovino Luca Nai, Messina Antonio, Sgroi Carmelo, Gallo Francesco, Nerla Roberto, Saccocci Matteo, D'Ascenzo Fabrizio, Conrotto Federico, Bettari Luca, Fiorina Claudia, Castriota Fausto, Poli Arnaldo, Petronio Anna Sonia, Oreglia Jacopo, Montorfano Matteo, Regazzoli Damiano, Reimers Bernhard, Barbanti Marco, Tamburino Corrado, Bedogni Francesco, Tarantini Giuseppe, Tespili Maurizio. Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.. International journal of cardiology. 2023. DOI: 10.1016/j.ijcard.2023.131236.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.